PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1

The present invention relates to compounds of formula (I). The compounds may be used to modulate activity of the HPK-1 protein, and thereby treat cancer, viral infection and immune-mediated disorders. La présente invention concerne des composés de formule (I). Les composés peuvent être utilisés pour...

Full description

Saved in:
Bibliographic Details
Main Authors PRYDE, David Cameron, GHOSH, Rajib, YADAV, Dharmendra B, DEBNATH, Sabyasachi, SHRIVASTAVA, Ritesh Kumar, BANERJEE, Monali, MIDDYA, Sandip Kumar, BASU, Sourav, SURYA, Arjun
Format Patent
LanguageEnglish
French
Published 23.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (I). The compounds may be used to modulate activity of the HPK-1 protein, and thereby treat cancer, viral infection and immune-mediated disorders. La présente invention concerne des composés de formule (I). Les composés peuvent être utilisés pour moduler l'activité de la protéine HPK-1, et ainsi traiter le cancer, une infection virale et des troubles à médiation immunitaire.
Bibliography:Application Number: WO2023GB52936